USPTO serial 79397841
STHLM3
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 14, 2025
- Examiner
- SINGER, MELANIE ALYSSA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STHLM3?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ronald E. Shapiro
Ronald E. Shapiro Shapiro and Silverstein PLLC1300 Pennsylvania Avenue NW Suite 700Washington, DC 20004United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and veterinary preparations and articles, namely, diagnostic test reagents for medical purposes for prostate cancer testing; diagnostic preparations and material preparations in the nature of pharmaceuticals for medical purposes being for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use in the nature of reagents for medical purposes; diagnostic test materials reagents for medical purposes for prostate cancer testing; diagnostic preparations for medical purposes; diagnostic agents for medical use | ACTIVE | — |
| 009 | Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer tests; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring proteins and genetics; educational apparatus and simulators, namely, medical diagnostics training simulators in the field of prostate cancer; scientific laboratory research instruments for the detection of proteins and genetics for medical research and training purposes; and parts and fittings for all the aforesaid goods included in this class, namely, computer peripherals and parts thereof | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments, namely, protein and genetics measurements instruments for diagnostic and treatment purposes; medical diagnostic, examination, and monitoring equipment for prostate cancer for medical treatment purposes; testing apparatus for medical purposes for prostate cancer detection; medical test instruments for diagnosis and treatment of prostate cancer; testing probes for medical diagnostic purposes; testing instruments for medical diagnostic purposes being for use in diagnosing prostate cancer; tools for medical diagnosis of prostate cancer, namely, tools for calculation of prostate cancer risk; apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus for diagnosing prostate cancer | ACTIVE | — |
| 042 | IT integration services; computer software development, programming and implementation for others; website hosting services; software as a service featuring computer software for calculating a prostate cancer risk score; rental of computer software for calculating cancer risk; providing temporary use of online non¬-downloadable computer software for calculating a prostate cancer risk score; application service provider, featuring computer software programs for calculating a prostate cancer risk score; scientific and technology services, namely, scientific research, analysis, and testing, and medical and pharmacological research services in the field of prostate cancer; conducting research clinical trials for others in the field of prostate cancer; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical research laboratory services in the field of prostate cancer; and advice, consultancy and information relating to the aforesaid, included in this class, namely, medical research laboratory services | ACTIVE | — |
| 044 | Human healthcare services, namely, disease management programs; medical services; medical testing services; medical diagnostic services; medical diagnostic testing services for prostate cancer; providing online information services relating to medical and diagnostic tests, namely information regarding prostate cancer tests for diagnosis and treatment purposes; prostate cancer screening services; prostate cancer medical testing services; prostate cancer diagnostic medical testing services; medical testing services relating to prostate cancer; taking of blood for medical testing in the nature of phlebotomy services; services for the medical testing of blood; performing diagnosis of diseases; medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, blood sampling and analysis; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease in the nature of medical diagnostic services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing medical information relating to medical results and diagnostic tests, namely, prostate cancer tests; providing medical diagnostic information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic and treatment purposes; rental of medical equipment for human healthcare; and advice, consultancy, and information relating to the aforesaid, included in this class, namely, medical diagnostic consulting and information services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by A3P Biomedical AB
- Other trademarks owned by A3P Biomedical AB
- Other trademarks owned by A3P Biomedical AB
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named STHLM3
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 24, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 24, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 14, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 19, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 19, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 14, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 14, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 26, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 13, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 13, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 13, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 6, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 7, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 30, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 20, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |